These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 36234746)

  • 1. Development of UPLC-MS/MS Method to Study the Pharmacokinetic Interaction between Sorafenib and Dapagliflozin in Rats.
    He X; Li Y; Ma Y; Fu Y; Xun X; Cui Y; Dong Z
    Molecules; 2022 Sep; 27(19):. PubMed ID: 36234746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo assessment of the pharmacokinetic interactions between donafenib and dapagliflozin, donafenib and canagliflozin in rats.
    He X; Li Y; Li Y; Guo C; Fu Y; Xun X; Wang Z; Dong Z
    Biomed Pharmacother; 2023 Jun; 162():114663. PubMed ID: 37027985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic Interactions between Canagliflozin and Sorafenib or Lenvatinib in Rats.
    Cui Y; Li Y; Guo C; Li Y; Ma Y; Dong Z
    Molecules; 2022 Aug; 27(17):. PubMed ID: 36080187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Pharmacokinetic Interaction Study of Sorafenib and Iced Teas in Rats Using UPLC-MS/MS: An Illustration of Beverage-Drug Interaction.
    Maher HM; Almomen A; Alzoman NZ; Shehata SM; Al-Subaie A
    Biomed Res Int; 2019; 2019():2410845. PubMed ID: 31871933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid Determination of Dapagliflozin in Rat Plasma by UHPLC-Q-Orbitrap MS and Its Application to a Pharmacokinetic Study.
    Wang LJ; Xi W; Yuan XL; Yang XH
    Chem Pharm Bull (Tokyo); 2023 Dec; 71(12):846-851. PubMed ID: 37793851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simple, fast and robust LC-MS/MS method for the simultaneous quantification of canagliflozin, dapagliflozin and empagliflozin in human plasma and urine.
    van der Aart-van der Beek AB; Wessels AMA; Heerspink HJL; Touw DJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Sep; 1152():122257. PubMed ID: 32663790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic interaction study of novel combination of palbociclib and sorafenib for hepatocellular carcinoma in SD rats.
    Paul D; Chandrakala P; Surendran S; Bitla P; Satheeshkumar N
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Feb; 1108():25-31. PubMed ID: 30660839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges in simultaneous extraction and chromatographic separation of metformin and three SGLT-2 inhibitors in human plasma using LC-MS/MS.
    Shah PA; Shrivastav PS; Sharma V; Yadav MS
    J Pharm Biomed Anal; 2019 Oct; 175():112790. PubMed ID: 31362250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common UGT1A9 polymorphisms do not have a clinically meaningful impact on the apparent oral clearance of dapagliflozin in type 2 diabetes mellitus.
    Naagaard MD; Chang R; Någård M; Tang W; Boulton DW
    Br J Clin Pharmacol; 2022 Feb; 88(4):1942-1946. PubMed ID: 34687551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a UPLC-MS/MS method for simultaneous detection of doxorubicin and sorafenib in plasma: Application to pharmacokinetic studies in rats.
    Altalal A; Almomen A; Alkholief M; Binkhathlan Z; Alzoman NZ; Alshamsan A
    Saudi Pharm J; 2023 Jul; 31(7):1317-1326. PubMed ID: 37323919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous determination of bioactive components of Radix Angelicae Sinensis-Radix Paeoniae Alba herb couple in rat plasma and tissues by UPLC-MS/MS and its application to pharmacokinetics and tissue distribution.
    Luo N; Li Z; Qian D; Qian Y; Guo J; Duan JA; Zhu M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jul; 963():29-39. PubMed ID: 24927419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous determination of caffeic acid derivatives by UPLC-MS/MS in rat plasma and its application in pharmacokinetic study after oral administration of Flos Lonicerae-Fructus Forsythiae herb combination.
    Zhou W; Shan J; Wang S; Ju W; Meng M; Cai B; Di L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Feb; 949-950():7-15. PubMed ID: 24441018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo assessment of potential for UGT-inhibition-based drug-drug interaction between sorafenib and tapentadol.
    Karbownik A; Miedziaszczyk M; Grabowski T; Stanisławiak-Rudowicz J; Jaźwiec R; Wolc A; Grześkowiak E; Szałek E
    Biomed Pharmacother; 2020 Oct; 130():110530. PubMed ID: 32712531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baicalin Enhanced Oral Bioavailability of Sorafenib in Rats by Inducing Intestine Absorption.
    Wei J; Liu R; Zhang J; Liu S; Yan D; Wen X; Tian X
    Front Pharmacol; 2021; 12():761763. PubMed ID: 34819863
    [No Abstract]   [Full Text] [Related]  

  • 15. A new HPLC-MS/MS method for the simultaneous quantification of SGLT2 inhibitors and metformin in plasma and its application to a pharmacokinetic study in healthy volunteers.
    Dias BCL; Fachi MM; de Campos ML; Degaut FLD; Peccinini RG; Pontarolo R
    Biomed Chromatogr; 2019 Nov; 33(11):e4663. PubMed ID: 31339572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UPLC-MS/MS method for the determination of Lenvatinib in rat plasma and its application to drug-drug interaction studies.
    Cui Y; Li Y; Fan L; An J; Wang X; Fu R; Dong Z
    J Pharm Biomed Anal; 2021 Nov; 206():114360. PubMed ID: 34508926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LC-MS/MS monitoring of the colorectal carcinoma cellular uptake and entrapment of sorafenib and its N-oxide active metabolite.
    Elawady T; Al-Abd AM; Khedr A; El-Enany N; Belal F
    J Pharm Biomed Anal; 2022 May; 213():114687. PubMed ID: 35240408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of UPLC-MS/MS method for studying the pharmacokinetic interactions of fuzuloparib with curcumin in rats.
    Wu H; Xie S; Chen X; Xia H; Shen Y; Xu RA; Tan W; Zhan R
    J Pharm Biomed Anal; 2024 Oct; 249():116383. PubMed ID: 39096626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous quantification of donafenib, sorafenib, and their N-oxide metabolites in rat plasma using a HPLC-MS/MS method.
    Lou Y; Sun Z; Chai Y; Qin H; Hu Q; Liu Y; Zheng X; Hu Y; Bao M; Gu J; Zhang Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Sep; 1229():123871. PubMed ID: 37717473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validated LC-MS/MS methods for the determination of dapagliflozin, a sodium-glucose co-transporter 2 inhibitor in normal and ZDF rat plasma.
    Aubry AF; Gu H; Magnier R; Morgan L; Xu X; Tirmenstein M; Wang B; Deng Y; Cai J; Couerbe P; Arnold M
    Bioanalysis; 2010 Dec; 2(12):2001-9. PubMed ID: 21110743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.